FCL.NS
Fineotex Chemical Limited [FCL.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FCL.NS Stock Summary
Top 10 Correlated ETFs
FCL.NS
Top 10 Correlated Stocks
FCL.NS
In the News
FCL.NS Financial details
Company Rating
Buy
Market Cap
39.84B
Income
1.05B
Revenue
5.24B
Book val./share
35.99
Cash/share
4.73
Dividend
0.8
Dividend %
0.22%
Employees
201
Optionable
No
Shortable
Yes
Earnings
31 Oct 2022
P/E
38.62
Forward P/E
-
PEG
4.26
P/S
7.73
P/B
10.17
P/C
77.05
P/FCF
17098.27
Quick Ratio
1.69
Current Ratio
2.27
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
9.48
EPS next Y
-
EPS next Q
-
EPS this Y
60.36%
EPS next Y
-
EPS next 5Y
-71.23%
EPS last 5Y
31.59%
Revenue last 5Y
23.36%
Revenue Q/Q
9.86%
EPS Q/Q
21.98%
-
-
-
-
SMA20
11.07%
SMA50
1.05%
SMA100
12.45%
Inst Own
-
Inst Trans
-
ROA
20%
ROE
56%
ROC
0.33%
Gross Margin
38%
Oper. Margin
25%
Profit Margin
20%
Payout
-
Shs Outstand
110.77M
Shs Float
31.16M
-
-
-
-
Target Price
-
52W Range
203.0-368.25
52W High
-0.96%
52W Low
+79.53%
RSI
75.79
Rel Volume
3.01
Avg Volume
478.8K
Volume
1.44M
Perf Week
11.64%
Perf Month
17.74%
Perf Quarter
15.37%
Perf Half Y
20.1%
-
-
-
-
Beta
0.912
-
-
Volatility
20.86%, 19.79%
Prev Close
0.11%
Price
364.45
Change
-0.15%
FCL.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 16.26 | 17.5 | 19.57 | 33.11 | 46.68 | |
| Net income per share | 2.02 | 1.17 | 3.84 | 4.98 | 7.97 | |
| Operating cash flow per share | 1.08 | 2.55 | 0.83 | 1.21 | 9.77 | |
| Free cash flow per share | 0.37 | 1.98 | -1.35 | -0.82 | 8.01 | |
| Cash per share | 1.72 | 2.32 | 2.52 | 2.78 | 5.53 | |
| Book value per share | 14.27 | 15.25 | 18.86 | 23.67 | 31.48 | |
| Tangible book value per share | 14.23 | 15.26 | 18.92 | 23.77 | 31.56 | |
| Share holders equity per share | 14.27 | 15.25 | 18.86 | 23.67 | 31.48 | |
| Interest debt per share | 0.23 | 0.28 | 0.33 | 0.21 | 0.73 | |
| Market cap | 4.61B | 1.64B | 7.3B | 20.01B | 25.82B | |
| Enterprise value | 4.49B | 1.49B | 7.11B | 19.72B | 25.51B | |
| P/E ratio | 20.48 | 12.51 | 17.15 | 36.27 | 29.23 | |
| Price to sales ratio | 2.55 | 0.84 | 3.36 | 5.46 | 4.99 | |
| POCF ratio | 38.39 | 5.77 | 78.86 | 149.62 | 23.86 | |
| PFCF ratio | 110.72 | 7.41 | -48.85 | -219.03 | 29.08 | |
| P/B Ratio | 2.91 | 0.96 | 3.49 | 7.63 | 7.4 | |
| PTB ratio | 2.91 | 0.96 | 3.49 | 7.63 | 7.4 | |
| EV to sales | 2.48 | 0.77 | 3.27 | 5.38 | 4.93 | |
| Enterprise value over EBITDA | 12.9 | 4.16 | 16.26 | 27.02 | 21.28 | |
| EV to operating cash flow | 37.39 | 5.26 | 76.74 | 147.46 | 23.58 | |
| EV to free cash flow | 107.84 | 6.76 | -47.53 | -215.87 | 28.74 | |
| Earnings yield | 0.05 | 0.08 | 0.06 | 0.03 | 0.03 | |
| Free cash flow yield | 0.01 | 0.13 | -0.02 | 0 | 0.03 | |
| Debt to equity | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | |
| Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Net debt to EBITDA | -0.35 | -0.4 | -0.45 | -0.4 | -0.25 | |
| Current ratio | 3.67 | 3.68 | 3.3 | 3.41 | 3.59 | |
| Interest coverage | 89.74 | 255.25 | 224.03 | 249.23 | 132.63 | |
| Income quality | 0.36 | 1.29 | 0.17 | 0.18 | 0.94 | |
| Dividend Yield | 0.01 | 0.02 | 0 | 0 | 0 | |
| Payout ratio | 0.11 | 0.24 | 0.03 | 0.09 | 0.07 | |
| Sales general and administrative to revenue | 0.01 | 0.04 | 0.03 | 0.02 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | |
| Capex to operating cash flow | -0.65 | -0.22 | -2.61 | -1.68 | -0.18 | |
| Capex to revenue | -0.04 | -0.03 | -0.11 | -0.06 | -0.04 | |
| Capex to depreciation | -7.83 | -5.36 | -16.41 | -8.96 | -4.54 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 25.49 | 20.08 | 40.36 | 51.51 | 75.16 | |
| ROIC | 0.15 | 0.13 | 0.15 | 0.2 | 0.24 | |
| Return on tangible assets | 0.12 | 0.06 | 0.16 | 0.17 | 0.21 | |
| Graham Net | 4.45 | 5.02 | 6.47 | 7.85 | 9.06 | |
| Working capital | 788.25M | 840.73M | 1.14B | 1.64B | 1.62B | |
| Tangible asset value | 1.58B | 1.7B | 2.1B | 2.63B | 3.5B | |
| Net current asset value | 780.45M | 835.22M | 1.13B | 1.62B | 1.59B | |
| Invested capital | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | |
| Average receivables | 534.67M | 662.44M | 878.81M | 1.18B | 1.19B | |
| Average payables | 158.82M | 221.39M | 301.06M | 478.04M | 530.66M | |
| Average inventory | 230.9M | 230.86M | 249.2M | 441.74M | 534.44M | |
| Days sales outstanding | 129.22 | 128.21 | 180.39 | 127.87 | 76.68 | |
| Days payables outstanding | 64.5 | 68.87 | 95.08 | 90.71 | 50.96 | |
| Days of inventory on hand | 77.42 | 62.12 | 74.22 | 91.97 | 50.89 | |
| Receivables turnover | 2.82 | 2.85 | 2.02 | 2.85 | 4.76 | |
| Payables turnover | 5.66 | 5.3 | 3.84 | 4.02 | 7.16 | |
| Inventory turnover | 4.71 | 5.88 | 4.92 | 3.97 | 7.17 | |
| ROE | 0.14 | 0.08 | 0.2 | 0.21 | 0.25 | |
| Capex per share | -0.71 | -0.56 | -2.18 | -2.03 | -1.75 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 12.14 | 9.86 | 12.46 | 11.95 | 13.11 | |
| Net income per share | 1.86 | 2 | 2.34 | 2.32 | 2.83 | |
| Operating cash flow per share | 0 | 0 | 0.02 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0.02 | 0 | 0 | |
| Cash per share | 3.64 | 0 | 5.54 | 0 | 4.73 | |
| Book value per share | 27.09 | 0 | 31.54 | 0 | 35.99 | |
| Tangible book value per share | 27.09 | 0 | 31.62 | 0 | 35.99 | |
| Share holders equity per share | 27.09 | 0 | 31.54 | 0 | 35.99 | |
| Interest debt per share | 0.04 | 0.02 | 0.59 | 0.02 | 0.18 | |
| Market cap | 38.91B | 27.99B | 25.77B | 33.31B | 35.45B | |
| Enterprise value | 38.65B | 27.99B | 25.47B | 33.31B | 35.2B | |
| P/E ratio | 47.28 | 31.58 | 24.95 | 32.43 | 28.26 | |
| Price to sales ratio | 28.97 | 25.62 | 18.71 | 25.19 | 24.4 | |
| POCF ratio | 0 | 0 | 10.87K | 0 | 0 | |
| PFCF ratio | 0 | 0 | 10.87K | 0 | 0 | |
| P/B Ratio | 12.99 | 0 | 7.39 | 0 | 8.89 | |
| PTB ratio | 12.99 | 0 | 7.39 | 0 | 8.89 | |
| EV to sales | 28.78 | 25.62 | 18.49 | 25.19 | 24.23 | |
| Enterprise value over EBITDA | 140.22 | 92.22 | 73.18 | 94.69 | 83.77 | |
| EV to operating cash flow | 0 | 0 | 10.74K | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 10.74K | 0 | 0 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0.02 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0.01 | 0 | 0 | |
| Net debt to EBITDA | -0.95 | 0 | -0.87 | 0 | -0.58 | |
| Current ratio | 4.71 | 0 | 3.59 | 0 | 2.27 | |
| Interest coverage | 116.43 | 145.07 | 130.57 | 160.78 | 153.85 | |
| Income quality | 0 | 0 | 0.01 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.02 | 0 | 0.01 | 0 | 0.01 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 33.67 | 0 | 40.71 | 0 | 47.87 | |
| ROIC | 0.07 | 0 | 0.07 | 0 | 0.08 | |
| Return on tangible assets | 0.06 | 0 | 0.06 | 0 | 0.06 | |
| Graham Net | 9.26 | 0 | 9.08 | 0 | 5.69 | |
| Working capital | 1.61B | 401.69M | 1.62B | 604.77M | 1.53B | |
| Tangible asset value | 3B | 0 | 3.5B | 0 | 3.99B | |
| Net current asset value | 1.58B | 401.69M | 1.59B | 604.77M | 1.49B | |
| Invested capital | 0 | 0 | 0.02 | 0 | 0 | |
| Average receivables | 566.99M | 566.99M | 543.04M | 543.04M | 755.3M | |
| Average payables | 183.06M | 183.06M | 236.79M | 236.79M | 437.84M | |
| Average inventory | 227.21M | 227.21M | 236.47M | 236.47M | 212.98M | |
| Days sales outstanding | 75.99 | 0 | 70.99 | 0 | 93.59 | |
| Days payables outstanding | 35.6 | 0 | 48.54 | 0 | 88.45 | |
| Days of inventory on hand | 44.18 | 0 | 48.47 | 0 | 43.03 | |
| Receivables turnover | 1.18 | 0 | 1.27 | 0 | 0.96 | |
| Payables turnover | 2.53 | 0 | 1.85 | 0 | 1.02 | |
| Inventory turnover | 2.04 | 0 | 1.86 | 0 | 2.09 | |
| ROE | 0.07 | 0 | 0.07 | 0 | 0.08 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
FCL.NS Frequently Asked Questions
What is Fineotex Chemical Limited stock symbol ?
Fineotex Chemical Limited is a IN stock and trading under the symbol FCL.NS
What is Fineotex Chemical Limited stock quote today ?
Fineotex Chemical Limited stock price is $364.45 today.
Is Fineotex Chemical Limited stock public?
Yes, Fineotex Chemical Limited is a publicly traded company.
Something similar
Company Profile
- Volume Average 478.8K
- Market Capitalization 39.84B
- Employee 201
- CEO Mr. Arindam Choudhuri
- Headquarters Mumbai,IN
- IPO Date 2015-01-15
-
Website
https://www.fineotex.com 
Fineotex Chemical Limited manufactures and sells textile chemicals, and auxiliary and specialty chemicals in India and internationally. The company provides specialty textile chemicals for pretreatment, dyeing, printing, and finishing processes; water treatment chemicals, paper adhesives, and defoamers; various chemicals, such as benzalkonium chloride (BKC), barite, hematite, magnesium chloride, and calcium chloride; water-based drilling fluid chemicals, including clay/shale inhibitors, lubricants, specialty chemicals, spotting fluids, and loss circulation additives, as well as oil-based drilling fluid chemicals. It also offers cleaning, and hygiene products comprising liquid detergents, surface and hand disinfectants, sanitizing tablets, hand sanitizers and wash liquids, multi surface disinfectant liquids, and air fresheners; and white phenyl and detergent cakes. The company's products are used in textile, home care, hygiene, mining, garment, water treatment, leather, construction, paint, agrochemicals, and adhesives sectors. Fineotex Chemical Limited was founded in 1979 and is headquartered in Mumbai, India.
